27 octobre 2012
Israeli pharmaceutical giant Teva gets FDA approval for leukemia drug
The U.S. Food and Drug Administration on Friday said it has approved a new leukemia treatment from Teva Pharmaceutical Industries Ltd to be sold under the brand name Synribo. The drug, also known as omacetaxine mepesuccinate, is approved to treat a type...